NOVO NORDISK A/S v. BECTON DICKINSON AND CO.

No. 96 Civ.9506(BSJ).

96 F.Supp.2d 309 (2000)

NOVO NORDISK A/S, Novo Nordisk of North America, Inc. and Novo Nordisk Pharmaceuticals Inc., Plaintiffs, v. BECTON DICKINSON AND COMPANY, Defendant.

United States District Court, S.D. New York.

May 8, 2000.


Attorney(s) appearing for the Case

John Paul Reiner, Robert B. Smith, White & Case, New York City, Edward V. Filardi, Skadden, Arps, Slate, Meagher & Flom, LLP, New York City, for Plaintiffs.

Douglas Sharrott, Fitzpatrick Cella Harper & Scinto, New York City, for Defendant.


OPINION and ORDER

JONES, District Judge.

Defendant Becton Dickinson has moved for summary judgment on four issues arguing: (1) that the '535 patent, '323 patent, and the '906 patent are invalid as anticipated under 35 U.S.C. § 102(b) in view of a June 1991 issue of Novo Nordisk's informational brochure, Medview, containing an article by Lene Lytzen; (2) that all claims of the '323 patent and claims 11-14 of the '906...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases